Blog

When the United Nations General Assembly Special Session (UNGASS) convenes in New York next Tuesday, delegates will be discussing global drug policy – including what to do about medical cannabis. This is a historic meeting, and the ramifications for national and international medical cannabis policy could be huge.

ASA would like to provide every delegate from the 180 nations represented with a groundbreaking report we prepared this year for the UN Commission on Narcotic Drugs.  The 91-page report, which was peer-reviewed at our annual conference in March, answers important scientific questions about medical cannabis, and outlines a pathway towards international reform.

Pictured: ASA Executive Director Steph Sherer and an international delegation from France, the Czech Republic, the Netherlands, and Jamaica delivering the report to the UNCND in March.

Help out by donating this week to get this report to every delegate at the UNGASS meeting. Our goal is to raise $5,000 to make it happen before next Tuesday!

This report matters for patients and researchers in the United States and elsewhere, because the UN Single Convention Treaty on Narcotics of 1961 is an obstacle for medical cannabis reform worldwide. We need the UN to change its policies, but the last comprehensive UN report on cannabis was published in 1935.

Delegates at UNGASS need the up-to-date information in our report to make recommendations based on modern science. They need to have better information to make better choices about medical cannabis.

This could be a global turning point for medical cannabis. But if we do not take this information directly to the delegates, there is no guarantee they will see it.

Please donate $50, $100, or whatever you can afford this week, so we can make history next week.

We are closer than ever to realizing our goal of safe and legal access to medical cannabis for everyone who needs it.  Thank you for helping us take this important next step.   

By the way... You can mail a check or money order to Americans for Safe Access at 1624 U Street NW, Suite 200, Washington, DC 20009.